Wellington Management Group
IMCR icon

Wellington Management Group’s Immunocore IMCR Stock Holding History

Wellington Management Group’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182M Buy
5,721,945
+1,015,777
+22% +$30M 0.03% 410
2026
Q1 		$142M Buy
4,706,168
+12,525
+0.3% +$405K 0.03% 457
2025
Q4 		$163M Sell
4,693,643
-87,246
-2% -$3.08M 0.03% 435
2025
Q3 		$174M Buy
4,780,889
+567,314
+13% +$19.3M 0.03% 417
2025
Q2 		$132M Sell
4,213,575
-1,918,145
-31% -$59.6M 0.02% 458
2025
Q1 		$182M Sell
6,131,720
-485,335
-7% -$14.6M 0.04% 366
2024
Q4 		$195M Sell
6,617,055
-431,778
-6% -$13.7M 0.04% 376
2024
Q3 		$219M Buy
7,048,833
+668,382
+10% +$24.3M 0.04% 371
2024
Q2 		$216M Buy
6,380,451
+633,181
+11% +$32.3M 0.04% 363
2024
Q1 		$374M Buy
5,747,270
+1,434,659
+33% +$98.5M 0.07% 279
2023
Q4 		$295M Buy
4,312,611
+399,201
+10% +$20.7M 0.05% 308
2023
Q3 		$203M Buy
3,913,410
+217,920
+6% +$12.9M 0.04% 366
2023
Q2 		$222M Buy
3,695,490
+320,181
+9% +$18.3M 0.04% 368
2023
Q1 		$167M Buy
3,375,309
+1,222,343
+57% +$68.7M 0.03% 433
2022
Q4 		$123M Buy
2,152,966
+1,478,233
+219% +$83.2M 0.02% 484
2022
Q3 		$31.7M Sell
674,733
-591,179
-47% -$28.2M 0.01% 782
2022
Q2 		$47.2M Sell
1,265,912
-76,447
-6% -$2.48M 0.01% 693
2022
Q1 		$40.1M Sell
1,342,359
-71,791
-5% -$1.81M 0.01% 829
2021
Q4 		$48.4M Buy
1,414,150
+362,075
+34% +$13.1M 0.01% 836
2021
Q3 		$39M Buy
1,052,075
+760,563
+261% +$25.7M 0.01% 900
2021
Q2 		$11.4M Buy
291,512
+44,154
+18% +$1.7M ﹤0.01% 1233
2021
Q1 		$10.5M Buy
+247,358
New +$11M ﹤0.01% 1224

Other funds holding IMCR

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Wellington Management Group's IMCR Position: Q2 2026 in Review

Wellington Management Group increased its Immunocore (IMCR) stake by 22% in Q2 2026, buying an estimated $30M and bringing the position to 5,721,945 shares worth $182M. The position accounts for 0.03% of the portfolio, ranked #410.

Wellington Management Group first reported a position in IMCR in Q1 2021 and has held it in 22 quarters since. The position peaked at $374M in Q1 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Wellington Management Group held 5,721,945 shares of Immunocore worth $182M as of Q2 2026.
  • Wellington Management Group bought 1,015,777 Immunocore shares in Q2 2026, an estimated $30M.
  • Immunocore made up 0.03% of Wellington Management Group's portfolio in Q2 2026, its #410 holding.
  • Wellington Management Group first reported a position in Immunocore in Q1 2021 and has held it in 22 quarters since.
  • Wellington Management Group's Immunocore position peaked at $374M in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.